Essentra (ESNT) H1 2025 earnings summary

Executive summary

• Revenue declined 1.1% year-over-year on a constant currency basis to £152.4m, with sequential improvement from a challenging end to 2024 and new order intake rising across all regions.

• Americas and APAC returned to growth, while EMEA contracted 4.5% but showed sequential improvement; APAC revenue up 9.5%, Americas up 0.7%.

• Adjusted operating profit was £16.5m (10.8% margin), down 19.8% year-over-year; strong cash conversion at 106%.

• Operational and commercial initiatives, including pricing, cost control, and footprint changes, are supporting performance.

• Active M&A pipeline and continued investment in new products and sustainability initiatives underpin medium-term growth.

Financial highlights

• Revenue: £152.4m for H1 2025; adjusted operating profit: £16.5m (10.8% margin); adjusted pre-tax profit: £12.5m.

• Adjusted EPS: 3.4p; interim dividend: 0.8p per share, to be paid in October.

• Gross profit: £66.5m (gross margin 43.6%), down from 46.4% due to volume, sales mix, and Turkish wage inflation.

• Adjusted free cash flow: £11.9m; net debt: £68.7m; net debt/adjusted EBITDA: 1.5x.

• Reported net profit: £0.3m, down from £2.5m in H1 2024.

Outlook and guidance

• H2 margins expected to improve, driven by commercial and operational actions; full-year margins expected to be down versus 2024, but sequential improvement anticipated.

• Board expectations and FY25 guidance remain unchanged; medium-term target: 18% adjusted operating margin by 2030.

• Order momentum and PMIs are positive; focus on market share growth, operational excellence, and selective bolt-on M&A.